Office of Innovation and Industry Alliances
Office of Innovation and Industry Alliances
To inquire about our available technologies, call our office (813) 745-6828
| Name & Description | Number |
|---|---|
| Vaccine Adjuvant: Flagellin-Based Adjuvant for Tumor Cell Vaccines that binds TLR5 | 04A028 |
| Antibodies: MARCO Antibodies for Enhanced Dendritic Cell Vaccine Efficacy | 07MB004 |
| Vaccine: Vaccines Using Synthetic Peptide-Poly IC Complexes that Elicit T-cell Responses Comparable to Live Vaccination | 11MA013 |
| TAG72-CD3: Bispecific Antibody for Targeted Cancer Immunotherapy | 14MB072 |
| Cancer Vaccine: Full-Length Variant Survivin Vaccine Potentiates Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma | 14MB098 |
| TLR9: CARs (chimeric antigen receptors) that Recognize TLR9 | 16MA025 |
| DOR: Delta opioid receptor ligand and anti-PD1 checkpoint inhibitor conjugates for immunotherapy of lung cancer | 16MA029 |
| AaPC: Artificial Antigen-Presenting Cells for Expanding TILs/MILs in Cancer Immunotherapy | 16MB050 |
| TAG72: CAR-T cell constructs (chimeric antigen receptors) that Recognize TAG72 | 16MB057 |
| IL-13Rα2: CAR-T cell constructs (chimeric antigen receptors) that Recognize IL-13Rα2 | 16MB069 |
| CD3-CD28: Bispecific Antibody for the Generation of CAR-T cells for Cancer Immunotherapy | 17MA007 |
| TILs: Simple and Rapid Method for Culture of TILs from Melanoma Tumor Fragments or Core Needle Biopsies of Solid Tumors | 17MA012 |
| TILs: Method to Increase TILs by Administering Fucose to a Patient | 17MB048 |
| CD83: CAR-T cell constructs (chimeric antigen receptors) that Recognize CD83 to prevent GVHD | 18MA007 |
| AaPC: Artificial Antigen-Presenting Cells with Heparin-Binding Domain and Protein L for Producing CAR-T Cells | 18MA019N |
| TILs: A New Digest Method for the Preparation of TILs | 18MA026N |
| Glioma Stem Cells: CAR-T Cell Constructs with Phage Display Derived Peptide Oligomers that Recognize Glioma Stem Cells | 18MA054 |
| Brain Mets: CAR-T Cell Constructs with Phage Display Derived Peptide Oligomers that Recognize Lung Cancer Brain Metastases | 18MA059 |
| Antibodies: Fully Human anti-PD1 Antibodies | 18MB061N |
| Antibodies: Fully Human anti-LAG3 Antibodies | 18MB062N |